New classifications for non-Hodgkin’s lymphoma

  • William G. Finn
  • Steven H. Kroft
Part of the Cancer Treatment and Research book series (CTAR, volume 99)


For decades, attempts to design clinically and biologically relevant classifications of non-Hodgkin’s lymphoma have been the topic of intense debate [1, 2, 3, 4, 5]. In recent years, our understanding of the basic biological aspects of malignant lymphoma has accelerated rapidly. Unfortunately, this explosion of knowledge has imparted extreme complexity to the subject of lymphoma classification. Much of this complexity reflects the true biologic diversity of lymphoid neoplasia. At times, however, this complexity has been aggravated by variation in interobserver reliability [6] and by the use of different terms assigned by different investigators to describe biologically identical cell types or disease entities [4,6]


Mantle Cell Lymphoma Anaplastic Lymphoma Kinase Anaplastic Large Cell Lymphoma Marginal Zone Lymphoma Posttransplantation Lymphoproliferative Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hiddemann W, Longo DL, Coiffier B, Fisher RI, Cabanillas F, Cavalli F, Nadler LM, De Vita VT, Lister TA, Armitage JO. 1996. Lymphoma classification —the gap between biology and clinical management is closing. Blood 88:4085–4089.PubMedGoogle Scholar
  2. 2.
    Kay HE. 1974. Letter: Classification of non-Hodgkin’s lymphomas. Lancet 2:586.PubMedGoogle Scholar
  3. 3.
    Higby DJ. 1979. [letter] A practical classification of lymphomas. N Engl J Med 300:1283.PubMedGoogle Scholar
  4. 4.
    Mason DY, Gatter KC. 1995. Not another lymphoma classification. Br J Haematol 90:493–497.PubMedGoogle Scholar
  5. 5.
    Rosenberg SA. 1994. Classification of lymphoid neoplasms. Blood84:1359–1360.PubMedGoogle Scholar
  6. 6.
    NCI Non-Hodgkin’s Classification Project Writing Committee. 1985. Classification of non-Hodgkin’s lymphomas. Reproducibility of major classification systems. Cancer 55:91–95.Google Scholar
  7. 7.
    Rappaport H, Winter W, Hicks E. 1956. Follicular lymphoma: a reevaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9:792–821.PubMedGoogle Scholar
  8. 8.
    Rappaport H. 1966. Tumors of the Hematopoietic System, 1st series ed. Armed Forces Institute of Pathology: Washington, D.C.Google Scholar
  9. 9.
    Warnke R, Weiss L, Chan J, Cleary M, Dorfman R. 1995. Nomenclature and classification of lymphoid tumors. In: Tumors of the Lymph Nodes and Spleen. Armed Forces Institute of Pathology: Washington, D.C.Google Scholar
  10. 10.
    Lukes RJ, Collins RD. 1974. Immunologic characterization of human malignant lymphomas. Cancer 34(Suppl):1488–1503.PubMedGoogle Scholar
  11. 11.
    Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld A, Van Unnik J. 1974. Classification of non-Hodgkin’s lymphomas. Lancet 2:406–408.Google Scholar
  12. 12.
    The Non-Hodgkin’s Lymphoma Pathologic Classification Project. 1982. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 49:2112–2135.Google Scholar
  13. 13.
    Simon R, Durrleman S, Hoppe RT, Bonadonna G, Bloomfield CD, Rudders RA, Cheson BD, Berard CW. 1988. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Ann Intern Med 109:939–945.PubMedGoogle Scholar
  14. 14.
    Kwak LW, Wilson M, Weiss LM, Horning SJ, Warnke RA, Dorfman RF. 1991. Clinical significance of morphologic subdivision in diffuse large cell lymphoma. Cancer 68:1988–1993.PubMedGoogle Scholar
  15. 15.
    Ersboll J, Schultz HB, Hougaard P, Nissen NI, Hou-Jensen K. 1985. Comparison of the working formulation of non-Hodgkin’s lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution. Cancer 55:2442–2458.PubMedGoogle Scholar
  16. 16.
    The Non-Hodgkin’s Lymphoma Classification Project. 1997. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89:3909–3918.Google Scholar
  17. 17.
    Stansfeld AG, Diebold J, Noel H, et al. 1988. Updated Kiel classification for lymphomas (letter). Lancet 1:292–293.PubMedGoogle Scholar
  18. 18.
    Lennert K, Feller A. 1992. Histopathology of Non-Hodgkin’s Lymphomas, 2nd ed. Springer-Verlag: New York.Google Scholar
  19. 19.
    Zukerberg LR, Medeiros LJ, Ferry JA, Harris NL. 1993. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100:373–385.PubMedGoogle Scholar
  20. 20.
    Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller AC. 1987. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 40:995–1015.PubMedGoogle Scholar
  21. 21.
    Chott A, Augustin I, Wrba F, Hanak H, Ohlinger W, Radaszkiewicz T. 1990. Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases. Hum Pathol 21:1117–1125.PubMedGoogle Scholar
  22. 22.
    Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G. 1991. Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classification. Histopathology 18:99–105.PubMedGoogle Scholar
  23. 23.
    Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392.PubMedGoogle Scholar
  24. 24.
    Chan JK, Banks PM, Cleary ML, et al. 1994. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology 25:517–536.PubMedGoogle Scholar
  25. 25.
    Chan JK, Banks PM, Cleary ML, et al. 1995. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol 103:543–560.PubMedGoogle Scholar
  26. 26.
    Dehner LP. 1995. Here we go again: a new classification of malignant lymphomas. A viewpoint from the trenches. Am J Clin Pathol 103:539–540.PubMedGoogle Scholar
  27. 27.
    Diebold J, Anderson J, Armitage J, MacLennan K, Muller-Hermelink H, Nathwani B, Weisenburger D. 1998. Diffuse aggressive B-cell lymphoma: a clinicopathologic analysis of 480 cases. Lab Invest 78:128A. (abstract)Google Scholar
  28. 28.
    Gascoyne R, Diebold J, Muller-Hermelink K, MacLennan K, Nathwani B, Weisenburger D. 1998. Non-Hodgkin’s lymphoma classification project (NHLCP): diffuse small B-cell lymphomas. Lab Invest 78:129A. (abstract)Google Scholar
  29. 29.
    MacKlennan K, Anderson J, Armitage J, Diebold J, Muller-Hermelink H, Nathwani B, Weisenburger D. 1998. Anaplastic large cell lymphoma (ALCL) of T/null-cell type is a distinctive clinicopathologic entity. Lab Invest 78:135A. (abstract)Google Scholar
  30. 30.
    Muller-Hermelink H, Anderson J, Armitage J, Diebold J, MacLennan K, Nathwani B, Weisenburger D. 1998. Peripheral T-cell lymphoma (PTCL): a clinicopathologic analysis of 96 cases. Lab Invest 78:136A. (abstract)Google Scholar
  31. 31.
    Nathwani B, Anderson J, Armitage J, Diebold J, MacLennan K, Muller-Hermelink H, Weisenburger D. 1998. A clinicopathologic comparison of 21 patients with nodal marginal zone lymphoma and 72 patients with MALT type lymphoma. Lab Invest 78:137A. (abstract)Google Scholar
  32. 32.
    Grogan T, Kjeldsberg C, Tubbs R, Dahlberg S, Braziel R, Foucar C, Leith C, Psier C, Gaynor E, Miller T, Fisher R. 1995. A Southwest Oncology Group (SWOG) analysis of the anaplastic large cell lymphoma entities in the Revised European American Lymphoma (REAL) classification. Lab Invest 72:111A. (abstract)Google Scholar
  33. 33.
    Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. 1997. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin’s lymphoma. Blood 89:4514–4520.PubMedGoogle Scholar
  34. 34.
    The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. 1993. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329:987–994.Google Scholar
  35. 35.
    Jaffe E, Berard C, Dibold J, Harris N, Chan J, Stein H, Vardiman J. 1997. Society for Hematopathology Program: Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 21:114–121.Google Scholar
  36. 36.
    Berard C, Dorfman R. 1974. Histopathology of malignant lymphomas. Clin Haematol 3:39.Google Scholar
  37. 37.
    Nanba K, Jaffe ES, Braylan RC, Soban EJ, Berard CW. 1977. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas. Am J Clin Pathol 68:535–542.PubMedGoogle Scholar
  38. 38.
    Banks PM, Chan J, Cleary ML, et al. 1992. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637–640.PubMedGoogle Scholar
  39. 39.
    Weisenburger DD, Armitage JO. 1996. Mantle cell lymphoma —an entity comes of age. Blood 87:4483–4494.PubMedGoogle Scholar
  40. 40.
    Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. 1997. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89:2067–2078.PubMedGoogle Scholar
  41. 41.
    Weisenburger DD. 1991. Non-Hodgkin’s lymphomas of primary follicle/mantle zone origin. Leukemia 5:26–29.PubMedGoogle Scholar
  42. 42.
    Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. 1990. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752–763.PubMedGoogle Scholar
  43. 43.
    Norton AJ, Matthews J, Pappa V, Shamash J, Love S, Rohatiner AZ, Lister TA. 1995. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249–256.PubMedGoogle Scholar
  44. 44.
    Plank L, Hansmann ML, Lennert K. 1993. Centrocytic lymphoma (letter). Am J Surg Pathol 17:638–639.PubMedGoogle Scholar
  45. 45.
    Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. 1994. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640–1645.PubMedGoogle Scholar
  46. 46.
    Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, Van den Berghe H, de Wolf-Peeters C. 1995. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 26:17–24.PubMedGoogle Scholar
  47. 47.
    Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT. 1987. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood 69:1617–1621.PubMedGoogle Scholar
  48. 48.
    Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC. 1991. Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4846–4853.PubMedGoogle Scholar
  49. 49.
    de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, van Krieken JH. 1995. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86:2715–2723.PubMedGoogle Scholar
  50. 50.
    Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. 1994. Cyclin D1 (Bcl-1:PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86–96.PubMedGoogle Scholar
  51. 51.
    Cousar JB, McGinn DL, Glick AD, List AF, Collins RD. 1987. Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called ‘monocytoid’ lymphocytes. Am J Clin Pathol 87:121–128.PubMedGoogle Scholar
  52. 52.
    Sheibani K, Burke JS, Swartz WG, Nademanee A, Winberg CD. 1988. Monocytoid B-cell lymphoma. Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer 62:1531–1538.PubMedGoogle Scholar
  53. 53.
    van den Oord JJ, de Wolf-Peeters C, De Vos R, Desmet VJ. 1985. Immature sinus histiocytosis. Light-and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes. Am J Pathol 118:266–277.PubMedGoogle Scholar
  54. 54.
    Piris MA, Rivas C, Morente M, Cruz MA, Rubio C, Oliva H. 1988. Monocytoid B-cell lymphoma, a tumour related to the marginal zone. Histopathology 12:383–392.PubMedGoogle Scholar
  55. 55.
    Isaacson PG, Spencer J. 1987. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445–462.PubMedGoogle Scholar
  56. 56.
    Hsi ED, Zukerberg LR, Schnitzer B, Harris NL. 1995. Development of extrasalivary gland lymphoma in myoepithelial sialadenitis. Mod Pathol 8:817–824.PubMedGoogle Scholar
  57. 57.
    DiGiuseppe JA, Corio RL, Westra WH. 1996. Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance. Curr Opin Oncol 8:232–237.PubMedGoogle Scholar
  58. 58.
    Fiche M, Caprons F, Berger F, Galateau F, Cordier JF, Loire R, Diebold J. 1995. Primary pulmonary non-Hodgkin’s lymphomas. Histopathology 26:529–537.PubMedGoogle Scholar
  59. 59.
    White WL, Ferry JA, Harris NL, Grove AS Jr. 1995. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 102:1994–2006.PubMedGoogle Scholar
  60. 60.
    Isaacson PG, Banks PM, Best PV, McLure SP, Muller-Hermelink HK, Wyatt JI. 1995. Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol 19:571–575.PubMedGoogle Scholar
  61. 61.
    Mattia AR, Ferry JA, Harris NL. 1993. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 17:574–587.PubMedGoogle Scholar
  62. 62.
    Kempton CL, Kurtin PJ, Inwards DJ, Wollan P, Bostwick DG. 1997. Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol 21:1324–1333.PubMedGoogle Scholar
  63. 63.
    Anscombe AM, Wright DH. 1985. Primary malignant lymphoma of the thyroid —a tumour of mucosa-associated lymphoid tissue: review of seventy-six cases. Histopathology 9:81–97.PubMedGoogle Scholar
  64. 64.
    Kumar S, Kumar D, Kaldjian EP, Bauserman S, Raffeld M, Jaffe ES. 1997. Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol 21:81–87.PubMedGoogle Scholar
  65. 65.
    Pelstring RJ, Essell JH, Kurtin PJ, Cohen AR, Banks PM. 1991. Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues. Am J Clin Pathol 96:738–745.PubMedGoogle Scholar
  66. 66.
    Bailey EM, Ferry JA, Harris NL, Mihm MC Jr, Jacobson JO, Duncan LM. 1996. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol 20:1011–1023.PubMedGoogle Scholar
  67. 67.
    Isaacson PG, Wotherspoon AC, Diss T, Pan LX. 1991. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 15:819–828.PubMedGoogle Scholar
  68. 68.
    Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P, Coiffier B. 1997. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15:1624–1630.PubMedGoogle Scholar
  69. 69.
    Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, Savio E, Capella C, Pedrinis E, Saletti P, Morandi E, Santandrea G, Cavalli F. 1997. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26:527–537.PubMedGoogle Scholar
  70. 70.
    Hsi ED, Eisbruch A, Greenson JK, Singleton TP, Ross CW, Schnitzer B. 1998. Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol 22:17–27.PubMedGoogle Scholar
  71. 71.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577.PubMedGoogle Scholar
  72. 72.
    Wotherspoon AC, Finn TM, Isaacson PG. 1995. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85:2000–2004.PubMedGoogle Scholar
  73. 73.
    Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE. 1997. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 8:979–985.PubMedGoogle Scholar
  74. 74.
    Mollejo M, Menarguez J, Lloret E, Sanchez A, Campo E, Algara P, Cristobal E, Sanchez E, Piris MA. 1995. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. Am J Surg Pathol 19:1146–1157.PubMedGoogle Scholar
  75. 75.
    Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe E. 1998. Nodal marginal zone lymphoma MALT and’ splenic’ type. Lab Invest 78:126A. (abstract)Google Scholar
  76. 76.
    Schmid C, Kirkham N, Diss T, Isaacson PG. 1992. Splenic marginal zone lymphoma. Am J Surg Pathol 16:455–466.PubMedGoogle Scholar
  77. 77.
    Hammer RD, Glick AD, Greer JP, Collins RD, Cousar JB. 1996. Splenic marginal zone lymphoma. A distinct B-cell neoplasm. Am J Surg Pathol 20:613–626.PubMedGoogle Scholar
  78. 78.
    Dunphy CH, Bee C, McDonald JW, Grosso LE. 1998. Incidental early detection of a splenic marginal zone lymphoma by polymerase chain reaction analysis of paraffin-embedded tissue. Arch Pathol Lab Med 122:84–86.PubMedGoogle Scholar
  79. 79.
    Rosso R, Neiman RS, Paulli M, Boveri E, Kindl S, Magrini U, Barosi G. 1995. Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol 26:39–46.PubMedGoogle Scholar
  80. 80.
    Mulligan SP, Matutes E, Dearden C, Catovsky D. 1991. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 78:206–209.PubMedGoogle Scholar
  81. 81.
    Isaacson PG, Matutes E, Burke M, Catovsky D. 1994. The histopathology of splenic lymphoma with villous lymphocytes. Blood 84:3828–3834.PubMedGoogle Scholar
  82. 82.
    Huang J, Finn W, Goolsby C, Variakojis D, Peterson L. In press. CD5 negative small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. Am J Clin Pathol.Google Scholar
  83. 83.
    Pittaluga S, Verhoef G, Criel A, Wlodarska I, Dierlamm J, Mecucci C, Van den Berghe H, De Wolf-Peeters C. 1996. ‘Small’ B-cell non-Hodgkin’s lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. Am J Surg Pathol 20:211–223.PubMedGoogle Scholar
  84. 84.
    Piris M, Brown DC, Gatter KC, Mason DY. 1990. CD30 expression in non-Hodgkin’s lymphoma. Histopathology 17:211–218.PubMedGoogle Scholar
  85. 85.
    Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS. 1991. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539–547.PubMedGoogle Scholar
  86. 86.
    Nakamura S, Takagi N, Kojima M, et al. 1991. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 68:118–129.PubMedGoogle Scholar
  87. 87.
    Vecchi V, Burnelli R, Pileri S, Rosito P, Sabattini E, Civino A, Pericoli R, Paolucci G. 1993. Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood. Med Pediatr Oncol 21:402–410.PubMedGoogle Scholar
  88. 88.
    de Bruin PC, Beljaards RC, van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JH, Kluin-Nelemans JC, Willemze R, Meijer CJ. 1993. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127–135.PubMedGoogle Scholar
  89. 89.
    Noorduyn LA, de Bruin PC, van Heerde P, van de Sandt MM, Ossenkoppele GJ, Meijer CJ. 1994. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas. J Clin Pathol 47:33–37.PubMedGoogle Scholar
  90. 90.
    Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, Berger F, Symann M, Petrella T, Lederlin P, Briere J. 1997. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 90:3727–3734.PubMedGoogle Scholar
  91. 91.
    Mason DY, Bastard C, Rimokh R, et al. 1990. CD30-positive large cell lymphomas (‘Ki-1 lymphoma’) are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161–168.PubMedGoogle Scholar
  92. 92.
    Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY. 1989. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (‘Ki-1 lymphoma’). Br J Haematol 71:31–36.PubMedGoogle Scholar
  93. 93.
    Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW. 1990. Morphology in Ki-1(CD30)-positive non-Hodgkin’s lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305–316.PubMedGoogle Scholar
  94. 94.
    Morris SW, Kirstein MN, Valentine MB, Dittmer K, Shapiro DN, Look AT, Saltman DL. 1995. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma (letter). Science 267:316–317.PubMedGoogle Scholar
  95. 95.
    Gascoyne R, Wu C, Chhanabhai M, Morris S, Pulford K, Mason D, Greiner T, Connor J, Vose J, Coldman A, Weisenburger D. 1998. Prognostic significance of ALK oncogene expression in anaplastic large cell lymphoma. Lab Invest 78:129A. (abstract)Google Scholar
  96. 96.
    Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe M-J, Haralambieva E, Pulford K, Pileri S, Morris S, Mason D, Delsol G. 1998. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91:2076–2084.PubMedGoogle Scholar
  97. 97.
    Pittaluga S, Wiodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C. 1997. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 151:343–351.PubMedGoogle Scholar
  98. 98.
    Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY. 1997. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89:1394–1404.PubMedGoogle Scholar
  99. 99.
    Frizzera G. 1992. Atypical lymphoproliferative disorders. In Knowles D (ed), Neoplastic Hematopathology. Williams and Wilkins: Baltimore, pp 459–495.Google Scholar
  100. 100.
    Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH Jr, McClain K, Simmons RL, Najarian JS. 1983. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356–369.PubMedGoogle Scholar
  101. 101.
    Hanto DW, Frizzera G, Gajl-Peczalska J, Purtilo DT, Klein G, Simmons RL, Najarian JS. 1981. The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma. Transplant Proc 13:756–760.PubMedGoogle Scholar
  102. 102.
    Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE. 1995. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552–565.PubMedGoogle Scholar
  103. 103.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. 1981. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253–4261.PubMedGoogle Scholar
  104. 104.
    Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL. 1981. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262–4279.PubMedGoogle Scholar
  105. 105.
    Dusenbery D, Nalesnik MA, Locker J, Swerdlow SH. 1997. Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol 16:489–496.PubMedGoogle Scholar
  106. 106.
    Hanto DW, Birkenbach M, Frizzera G, Gajl-Peczalska KJ, Simmons RL, Schubach WH. 1989. Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 47: 458–464.Google Scholar
  107. 107.
    Locker J, Nalesnik M. 1989. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977–987.PubMedGoogle Scholar
  108. 108.
    Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. 1989. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 92:177–185.PubMedGoogle Scholar
  109. 109.
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J. 1988. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173–192.PubMedGoogle Scholar
  110. 110.
    Chadburn A, Cesarman E, Knowles D. 1997. Classification of post-transplantation lymphoproliferative disorders (PT-LPDs) based on morphologic and molecular genetic features has clinical relevance. Lab Invest 77:121A. (abstract)Google Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1999

Authors and Affiliations

  • William G. Finn
  • Steven H. Kroft

There are no affiliations available

Personalised recommendations